Image

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Trial of Cretostimogene for bladder cancer not responding to BCG.

Recruiting
18 years and older
All
Phase 3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for people with a type of bladder cancer called Non-Muscle Invasive Bladder Cancer (NMIBC) that hasn't responded to another treatment known as Bacillus-Calmette-Guerin (BCG). It's a Phase 3 study, meaning it's in a late stage to see how well the drug, Cretostimogene, works. The study is open to adults over 18 years old who have a cancer that did not get better with BCG. Two groups are involved: Cohort C and Cohort P.

Cohort C includes 115 patients with a specific type of bladder cancer, and it's no longer accepting new patients. Cohort P aims to enroll 75 patients in Japan and the US with another type of bladder cancer, and it is open for enrollment.

  • Duration: The study requires multiple visits to the clinic for various tests and procedures.
  • Eligibility: You must have specific types of bladder cancer and have not responded to BCG treatment.
  • Risks: Includes potential side effects and undergoing medical procedures like biopsies and cystoscopies.
Print
Study details
    Non Muscle Invasive Bladder Cancer
    High-grade Ta/ T1 Papillary Disease Bladder Cancer

NCT04452591

CG Oncology, Inc.

30 March 2025

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.